165 results on '"Martincich, Laura"'
Search Results
2. A survey by the European Society of Breast Imaging on the implementation of breast diffusion-weighted imaging in clinical practice
3. Mammographic density: Comparison of visual assessment with fully automatic calculation on a multivendor dataset
4. Structured reporting of x-ray mammography in the first diagnosis of breast cancer: a Delphi consensus proposal
5. Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging
6. Supplementary Table 3 from Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study
7. Supplementary Table 2 from Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study
8. Supplementary Table 1 from Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study
9. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis
10. Nipple-sparing mastectomy: external validation of a three-dimensional automated method to predict nipple occult tumour involvement on preoperative breast MRI
11. Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa)
12. Primary tumor location predicts the site of local relapse after nipple–areola complex (NAC) sparing mastectomy
13. Attitudes and perceptions of radiologists towards online (virtual) oncologic multidisciplinary team meetings during the COVID-19 pandemic—a survey of the European Society of Oncologic Imaging (ESOI)
14. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey
15. Recommendations for breast imaging follow-up of women with a previous history of breast cancer: position paper from the Italian Group for Mammography Screening (GISMa) and the Italian College of Breast Radiologists (ICBR) by SIRM
16. Neoadjuvant Therapy in Breast Cancer
17. MRI to predict nipple‐areola complex (NAC) involvement: An automatic method to compute the 3D distance between the NAC and tumor
18. Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis
19. Mammographic density: Comparison of visual assessment with fully automatic calculation on a multivendor dataset
20. Breast MRI: EUSOBI recommendations for women’s information
21. Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patients
22. Nipple–areola complex sparing mastectomy with periareolar pexy for breast cancer patients with moderately ptotic breasts
23. Correlations between diffusion-weighted imaging and breast cancer biomarkers
24. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer
25. Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer
26. Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer
27. Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging
28. Performance of a fully automatic lesion detection system for breast DCE-MRI
29. Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM
30. DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING IN MONITORING BONE METASTASES IN BREAST CANCER PATIENTS RECEIVING BISPHOSPHONATES AND ENDOCRINE THERAPY
31. DYNAMIC CONTRAST-ENHANCED MRI IN MONITORING RESPONSE TO PRIMARY CHEMOTHERAPY IN BREAST CANCER
32. Do we really need new contrast agents for MR-mammography?
33. Screening women at intermediate risk: harm or charm?
34. Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.
35. Radiomics for pretreatment prediction of pathological response to neoadjuvant therapy using magnetic resonance imaging: Influence of feature selection
36. A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features
37. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey
38. Additional file 1: of Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
39. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): Interim results
40. Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study
41. Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
42. MRI and intraoperative pathology to predict nipple–areola complex (NAC) involvement in patients undergoing NAC-sparing mastectomy
43. Mammographic density: Comparison of visual assessment with fully automatic calculation on a multivendor dataset
44. Breast cancer surveillance.
45. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer
46. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
47. A Fully Automatic Multiscale 3-Dimensional Hessian-Based Algorithm for Vessel Detection in Breast DCE-MRI
48. Variation of Breast Vascular Maps on Dynamic Contrast-Enhanced MRI After Primary Chemotherapy of Locally Advanced Breast Cancer
49. Multicenter, Double-Blind, Randomized, Intraindividual Crossover Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for Breast MR Imaging (DETECT Trial)
50. Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.